4 results about "Disease outcome" patented technology

The application discloses a pig disease diagnosis and treatment teaching training method, device and equipment based on AR, which comprises the following steps: loading a three-dimensional sick pig model corresponding to the current teaching scene through an AR device, and presenting the current symptom performance including visual elements and sound at the corresponding part of the three-dimensional sick pig model; receiving the diagnosis and treatment decision input by a user according to the current symptom performance; analyzing the diagnosis and treatment decision based on a preset pharmacology-pathology response model, updating the symptom state of the three-dimensional sick pig model according to the analysis result, and presenting the updated symptom state in real time as corresponding AR visual effects; when the user confirms the completion of the diagnosis and treatment operation based on the updated symptom state, comprehensively scoring the drug selection accuracy, dosage rationality, processing timeliness and diagnosis and treatment process integrity of the user in the diagnosis and treatment process, and generating a teaching evaluation report. The interactive training scheme can simulate a complete diagnosis and treatment process, support autonomous decision-making and dynamically feedback the disease outcome, and improves the teaching interactivity.

The invention relates to methods for diagnosing, predicting disease development, disease progression and / or disease outcome, predicting susceptibility to treatment, and / or classification in the context of diseases or disorders of the female reproductive tract, in particular endometriosis, wherein biomarkers of Table 1 are determined, e.g. CCL5 and / or NEAT1. The invention further relates to pharmaceutical products for use in patients stratified according to the methods of the invention and to compositions comprising reagents for the detection of the biomarkers of Table 1 for the diagnosis of diseases or disorders of the female reproductive tract.

Provided herein are methods, compounds, and compositions for safely reducing thrombopoietin in a cell or an individual. Such methods, compounds, and compositions maintain platelet count within a safe hemostatic range. Such methods, compounds, and compositions are useful to safely treat, prevent, or ameliorate a disease that can benefit from platelet count reduction in an individual. Such methods, compounds, and compositions are useful for treating or preventing diseases in which thrombopoietin contributes to the presence or activation of platelets contributes to and promotes disease initiation or progression, and / or adversely affects disease outcome.